Showing results (491-500 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|June 9, 2023
Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021)Nizar M Mhaidat, Osama Y Alshogran, Shoroq M Altawalbeh, et al.Expert Opinion on Drug Safety|June 9, 2023
Adverse events of guselkumab in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting systemDao-Chun Xiang, Wei Chen, Zhi-Wen Fu, et al.Expert Opinion on Drug Safety|October 21, 2011
Comparative risks of non-prescription analgesics: a structured topic review and research prioritiesEric J Lavonas, James F Fries, Daniel E Furst, et al.Expert Opinion on Drug Safety|August 20, 2014
Calcium supplementation in chronic kidney diseaseSushant Ramdas Taksande, Elaine M WorcesterExpert Opinion on Drug Safety|May 27, 2026
Tirzepatide data: safety always comes first!Miodrag Janić, Syed Arman Rabbani, Mohamed El-Tanani, et al.Expert Opinion on Drug Safety|March 30, 2026
Insights gained from drug utilization research to improve safe clinical practice for children and adolescents in DenmarkHelene Kildegaard, Anton PottegardExpert Opinion on Drug Safety|May 12, 2026
Recent advances in trastuzumab and its antibody-drug conjugates-related liver injuryLiyi Chen, Guo-H Li, Chun-Y LiExpert Opinion on Drug Safety|April 25, 2026
Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapiesAlessandro Ferretti, Antonella Riva, Lorenzo Perilli, et al.Expert Opinion on Drug Safety|March 31, 2026
Safe prescribing of antihypertensive drugs in the elderly and managing the risk of adverse eventsSiddhant Passey, Maheen Erum, Nandan Patel, et al.Expert Opinion on Drug Safety|February 23, 2026
Chronic sequelae of immune-related adverse eventsSean Ngo, Jarrett Rong, Raakhi Menon, et al.Pageof 281